SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy is currently navigating volatility as the market digests lockup expirations and share supply dynamics, while the community remains intensely focused on the stock's role as a primary beneficiary of surging AI-driven electricity demand. Investors are actively debating whether these pullbacks represent an attractive entry point for a long-term infrastructure play or a deeper technical correction for the nuclear sector.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is surging as investors react positively to reports of a new cloud-computing initiative designed to monetize the company's excess AI compute capacity. While community sentiment is divided, with some expressing skepticism regarding Meta's strategic pivot and capital efficiency, others view this as a potential revenue-generating shift that could improve long-term margins and ROI.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant volatility and trading momentum as investors pivot their focus toward the company's expanding oncology pipeline and the upcoming FDA advisory committee vote on its mRNA-based influenza vaccine. Community sentiment remains deeply divided, with bulls highlighting the platform's long-term diversification strategy while bears focus on regulatory hurdles, high short interest, and ongoing debates regarding mRNA technology.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending due to significant retail interest in a potential short squeeze, fueled by its low float and high short interest compared to sector peers. The community is actively debating the stock's turnaround potential and comparing it to other high-volatility meme plays, while investors monitor for upward momentum following recent debt refinancing initiatives.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending downward following reports that Meta may enter the AI cloud infrastructure market by monetizing its excess compute capacity, sparking investor concerns over potential increased competition and pricing pressure. While the market reaction has been swift, community discussions remain divided between those viewing the news as an overblown fear tactic and others who argue the shift signals a structural threat to the neocloud business model.

Invesco DB US Dollar Index Bullish Fund - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

The Invesco DB US Dollar Index Bullish Fund is trending as market participants closely monitor the fund's inverse relationship with precious metals and its sensitivity to Federal Reserve rate expectations and Middle East geopolitical developments. Traders are actively discussing the potential impact of central bank policies and global liquidity shifts on the dollar's strength against a basket of currencies.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is trending due to reports that its advanced manufacturing capacity remains structurally constrained despite aggressive capital expenditure, fueling sustained AI-driven demand and institutional focus on its pricing power. The community is actively debating the company's long-term dominance in the semiconductor supply chain and assessing how its critical role in advanced node fabrication and packaging influences global AI investment cycles.

The Kroger Co. engages in the retail grocery business with added convenience to retail pharmacies and fuel centers. Its main focus is on growing households and increasing customer loyalty by delivering great value and convenience, and investing in four strategic pillars: Fresh, Brands, Data & Personalization and Seamless. Its brands include Big K, Smart Way, Heritage Farm, Simple Truth, and Simple Truth Organic. The company was founded by Barney Kroger in 1883 and is headquartered in Cincinnati, OH.

Kroger Co.

Kroger is attracting investor attention following a series of strategic updates, including a significant two-billion-dollar increase to its share buyback program and continued regional expansion efforts. Community discussion is focused on the stock's stability as a consumer staple and its role as a defensive play, with many traders actively monitoring its bounce from recent lows.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending as investors react to a significant multi-billion dollar AI infrastructure contract and the completion of a major capital platform acquisition, driving high-volume activity. The community is actively debating the stock's long-term valuation relative to its expanding project backlog, with bulls focused on potential short squeezes and revenue acceleration, while bears remain skeptical about the firm's financing model and historical execution.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is driving market conversation following a definitive agreement to acquire Terns Pharmaceuticals for $6.7 billion, a strategic move to bolster its oncology pipeline ahead of the looming Keytruda patent cliff. Investors are now actively debating whether this signals a broader M&A frenzy, with community sentiment split between those praising the premium deal and those speculating on which high-potential biotech might be the next buyout target.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last?

CVRx (CVRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

CVRx CFO Oasheim To Step Down

(RTTNews) - Medical device maker CVRx, Inc. (CVRX) said on Tuesday that its Chief Financial Officer Jared Oasheim will step down to pursue other opportunities, and the company has begun a search for his successor...

CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy

CVRX stock gains after Humana adds Medicare Advantage coverage for Barostim therapy, boosting reimbursement momentum and patient access.

Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX)

CVRx (CVRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

CVRx (CVRX) Reports Q1 Loss, Beats Revenue Estimates

CVRx (CVRX) delivered earnings and revenue surprises of +1.32% and +3.69%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Pacific Biosciences of California (PACB) Reports Q1 Loss, Lags Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of +29.41% and -9.32%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

CVRx (CVRX) Projected to Post Quarterly Earnings on Monday

CVRx (NASDAQ:CVRX) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-cvrx-inc-stock...

CVRx (CVRX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for CVRx (CVRX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

CVRx, Inc. (NASDAQ:CVRX) Receives Average Rating of "Moderate Buy" from Analysts

CVRx, Inc. (NASDAQ:CVRX - Get Free Report) has earned an average rating of "Moderate Buy" from the six analysts that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a buy recommendation and two have is...

CVRx (NASDAQ:CVRX) Earns "Buy" Rating from Canaccord Genuity Group

Canaccord Genuity Group reiterated a "buy" rating and set a $10.00 price objective on shares of CVRx in a research report on Tuesday...

CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the following geographical segments: United States, Germany, and Other Countries. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2001 and is headquartered in Minneapolis, MN.

CVRx Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.52	--	--	N/A
Q1 '26	-$0.50	-$0.50	0.85%	BEAT
Q4 '25	-$0.44	-$0.46	-4.87%	MISSED
Q3 '25	-$0.50	-$0.49	2.37%	BEAT
Q2 '25	-$0.52	-$0.57	-9.55%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

CVRXCVRx Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest CVRX News